Researchers Identify Biomarkers in Blood to Predict Liver Cancer

Team of Mass General Brigham, Beth Israel Deaconess Medical Center investigators identify early detection opportunity to improve risk prediction and create therapeutic treatment options for patients 

Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for cure. A new study led by investigators from Mass General Brigham and Beth Israel Deaconess Medical Center suggests that proteins detectable in the blood could improve predictions about risk of liver cancer years before typical diagnosis. Results were published May 1, 2024 in JNCI. The article is titled“Pre-Diagnostic Plasma Proteomics Profile for Hepatocellular Carcinoma.”

Login Or Register To Read Full Story